Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 209,100 | 227,891 | 227,894 | 253,199 | 207,163 |
| Receivables | 692,388 | 704,909 | 686,264 | 672,271 | 620,483 |
| Inventories | 958,233 | 998,012 | 1,011,269 | 988,955 | 864,852 |
| TOTAL | $2,304,585 | $2,367,830 | $2,337,815 | $2,325,156 | $2,033,697 |
| Non-Current Assets | |||||
| PPE Net | 533,985 | 537,856 | 528,778 | 522,745 | 487,376 |
| Intangibles | 3,375,420 | 3,322,640 | 3,353,302 | 3,354,036 | 2,276,994 |
| Other Non-Current Assets | 526,796 | 523,382 | 493,984 | 474,167 | 379,493 |
| TOTAL | $4,436,201 | $4,383,878 | $4,376,064 | $4,350,948 | $3,143,863 |
| Total Assets | $6,740,786 | $6,751,708 | $6,713,879 | $6,676,104 | $5,177,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 177,048 | 150,756 | 161,896 | 196,003 | 181,485 |
| Accrued Expenses | 348,263 | 365,660 | 347,354 | 312,169 | 324,055 |
| TOTAL | $770,802 | $758,533 | $761,691 | $732,714 | $692,659 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,351,511 | 1,431,234 | 1,575,963 | 1,790,689 | 785,436 |
| Deferred Revenues | 146,718 | 138,072 | 141,043 | 133,909 | 108,195 |
| Other Non-Current Liabilities | 158,933 | 222,202 | 221,826 | 204,231 | 157,128 |
| TOTAL | $1,719,608 | $1,863,272 | $2,019,679 | $2,205,263 | $1,052,014 |
| Total Liabilities | $2,490,410 | $2,621,805 | $2,781,370 | $2,937,977 | $1,744,673 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 147,092 | 147,071 | 146,931 | 146,909 | 146,484 |
| Common Shares | 588 | 588 | 588 | 588 | 586 |
| Retained earnings | 4,401,841 | 4,253,016 | 4,088,057 | 3,920,197 | 3,759,783 |
| Other shareholders' equity | -320,404 | -272,784 | -262,133 | -270,424 | -406,384 |
| TOTAL | $4,250,376 | $4,129,903 | $3,932,509 | $3,738,127 | $3,432,887 |
| Total Liabilities And Equity | $6,740,786 | $6,751,708 | $6,713,879 | $6,676,104 | $5,177,560 |